Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
0.706
+0.026 (3.84%)
At close: Apr 26, 2024, 4:00 PM
0.700
-0.006 (-0.86%)
After-hours: Apr 26, 2024, 7:48 PM EDT
Aptevo Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aptevo Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for APVO.
Recommendation Trends
| Rating | Dec '21 | Jan '22 | Feb '22 | Mar '22 | Apr '22 | May '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $3,036 → $880 | Buy | Maintains | $3,036 → $880 | +124,528.24% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,816 → $2,200 | Strong Buy | Maintains | $2,816 → $2,200 | +311,470.60% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,408 → $3,036 | Buy | Maintains | $1,408 → $3,036 | +429,867.43% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $7,392 | Strong Buy | Initiates | $7,392 | +1,046,777.21% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $4,312 | Buy | Initiates | $4,312 | +610,578.37% | Sep 9, 2016 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-32.13
from -62.48
EPS Next Year
-10.71
from -32.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 77.9M | 102.1M |
| Avg | n/a | n/a | n/a | 75.7M | 99.2M |
| Low | n/a | n/a | n/a | 72.7M | 95.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 34.8% |
| Avg | - | - | - | - | 31.0% |
| Low | - | - | - | - | 25.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -33.08 | -11.03 | -7.35 | 1.13 | 1.64 |
| Avg | -32.13 | -10.71 | -7.14 | 1.10 | 1.59 |
| Low | -30.87 | -10.29 | -6.86 | 1.06 | 1.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 48.7% |
| Avg | - | - | - | - | 44.4% |
| Low | - | - | - | - | 38.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.